HER2 testing in breast cancer: NCCN Task Force report and recommendations.

@article{Carlson2006HER2TI,
  title={HER2 testing in breast cancer: NCCN Task Force report and recommendations.},
  author={Robert W. Carlson and Susan J. Moench and M Elizabeth Hale Hammond and Edith A. Perez and Harold J. Burstein and Donald Craig Allred and Charles Le. Vogel and Lori J. Goldstein and George Somlo and William John Gradishar and Clifford A Hudis and Mohammad Jahanzeb and Azadeh Stark and Antonio C. Wolff and Michael F Press and Eric P. Winer and Soonmyung Paik and Britt-marie Ljung},
  journal={Journal of the National Comprehensive Cancer Network : JNCCN},
  year={2006},
  volume={4 Suppl 3},
  pages={
          S1-22; quiz S23-4
        }
}
The NCCN HER2 Testing in Breast Cancer Task Force was convened to critically evaluate the ability of the level of HER2 expression or gene amplification in breast cancer tumors to serve as a prognostic and a predictive factor in the metastatic and adjuvant settings, to assess the reliability of the methods of measuring HER2 expression or gene amplification in the laboratory, and to make recommendations regarding the interpretation of test results. The Task Force is a multidisciplinary panel of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 79 CITATIONS

Similar Papers

Loading similar papers…